Category: <span>Clinical Practice</span>

Home / Clinical Practice
Patients receiving steroids are more than twice as likely to develop diabetes, UK study finds
Post

Patients receiving steroids are more than twice as likely to develop diabetes, UK study finds

September 8, 2024 by Diabetologia Credit: Unsplash/CC0 Public Domain Patients who are being treated with systemic glucocorticoids are more than twice as likely to develop diabetes as those not receiving the treatment, the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Madrid, Spain (9-13 September) will hear. Glucocorticoids (sometimes known...

Post

Medical Minute: New Procedure Offers Relief For High Blood Pressure, Without Unwanted Side Effects

A new medical procedure offers relief for high blood pressure without the side effects commonly found with traditional treatments.Saturday, September 7th 2024, 11:09 am By: News 9, CBS News Nearly half of all adults in the U.S. have high blood pressure, and many don’t know it. For some, lifestyle changes can help, while others may...

Lung complications + rheumatoid arthritis increase risk for lung cancer
Post

Lung complications + rheumatoid arthritis increase risk for lung cancer

September 8, 2024 by Lori Solomon The risk for lung cancer is high in patients with rheumatoid arthritis (RA) and pulmonary complications, according to a study published online Sept. 3 in Modern Rheumatology. Shunsuke Mori, M.D., Ph.D., from the Kumamoto Saishun Medical Center in Koshi, Japan, and colleagues assessed the incidence and predictive factors of...

Post

FDA Approves JAK Inhibitor Deuruxolitinib for Alopecia Areata

The US Food and Drug Administration (FDA) has approved the oral Janus kinase (JAK) inhibitor deuruxolitinib for the treatment of adults with severe alopecia areata. The development, which was announced in a July 25, 2024, news release from the drug’s manufacturer Sun Pharma, is based on data from two pivotal randomized, double-blind, placebo-controlled phase 3...

Post

Alopecia Areata: What Happens When Baricitinib Responders Stop Treatment?

Medscape Medical News > MedBrief Deepa Varma August 14, 2024 TOPLINE:Among patients with severe alopecia areata (AA) who have significant hair growth with baricitinib, continuing treatment is needed to maintain hair regrowth, according to the results of a randomized study. METHODOLOGY:Researchers conducted a treatment withdrawal substudy of a randomized, placebo-controlled, phase 3 clinical trial, BRAVE-AA1,...

Ulcers, damage to upper gastrointestinal tract linked to increased risk of Parkinson’s disease
Post

Ulcers, damage to upper gastrointestinal tract linked to increased risk of Parkinson’s disease

September 6, 2024 by Jacqueline Mitchell, Beth Israel Deaconess Medical Center Survival curves for time to Parkinson disease diagnosis. Credit: JAMA Network Open (2024). DOI: 10.1001/jamanetworkopen.2024.31949A study led by researchers at Beth Israel Deaconess Medical Center (BIDMC) found the risk of developing Parkinson’s disease was 76% higher among those with a history of damage to...

Post

Dementia Deemed Highly Preventable: Here’s How

JoAnn E. Manson, MD, DrPH DISCLOSURES | August 14, 2024 Hello. This is Dr JoAnn Manson, professor of medicine at Harvard Medical School and Brigham and Women’s Hospital. I’d like to talk with you about a new report on the preventability of dementia that is both exciting and paradigm-shifting. The new study, published in The...